V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10003905 | 10002460 | 1.76 | 94.2 | Disease modification (D) | 2017-08-12 | 2017-08-31 | ABVD | 02 | N | 10496961 | CTD |
| 10003906 | 10002461 | 1.68 | 49.9 | Palliative (P) | 2017-01-05 | 2017-01-21 | Bortezomib + Cyclophos + Dex | 2 | Y | 10497360 | AZACITIDINE |
| 10003907 | 10002461 | 1.79 | 81.1 | Palliative (P) | null | 2017-06-03 | Azacitidine | N | N | 10497360 | CAPECITABINE + GEMCITABINE |
| 10003908 | 10002462 | 1.71 | 86.6 | Palliative (P) | 2018-05-13 | 2018-05-13 | Chlorambucil | N | N | 10497601 | EC |
| 10003909 | 10002463 | null | 81.8 | Palliative (P) | 2017-05-07 | 2017-06-12 | Temozolomide + RT | N | N | 10497639 | BORTEZOMIB |
| 10003910 | 10002464 | 1.79 | 65 | Curative (C) | 2018-05-03 | 2018-05-23 | Temozolomide + RT | N | N | 10497700 | ABIRATERONE |
| 10003911 | 10002465 | 1.69 | 81.3 | Curative (C) | null | 2016-09-25 | Azacitidine | N | N | 10498007 | BORTEZOMIB |
| 10003912 | 10002466 | null | 69.9 | Palliative (P) | 2017-09-14 | 2017-09-16 | Irinotecan + Modified De Gramont | 2 | N | 10498010 | IRINOTECAN + MDG |
| 10003913 | 10002467 | 1.55 | 73.1 | Curative (C) | 2014-04-02 | 2014-04-23 | CTD | N | N | 10498076 | ABVD |
| 10003914 | 10002468 | 1.71 | 72.2 | Curative (C) | 2016-09-12 | 2016-09-25 | CYCLOPHOSPHAMIDE + THALIDOMIDE | Y | N | 10498390 | FLUOROURACIL + MITOMYCIN + RT |
| 10003915 | 10006536 | 1.72 | null | Curative (C) | 2018-06-01 | 2018-06-08 | Bortezomib +/- Dexamethasone | 02 | N | 10498592 | CHLORAMBUCIL |
| 10003916 | 10002469 | 1.83 | null | Adjuvant (A) | 2017-10-23 | 2017-10-25 | Bortezomib + CYCLOPHOSPHAMIDE | N | N | 10498611 | CVD |
| 10003917 | 10002469 | 1.81 | 97 | Curative (C) | 2018-09-16 | 2018-09-16 | CAPECITABINE + GEMCITABINE | 2 | N | 10498611 | CAPECITABINE + GEMCITABINE |
| 10003918 | 10002469 | 1.52 | 80.8 | Curative (C) | 2018-04-04 | 2018-04-06 | Cisplatin 100 + RT(H&N) 1 day | 02 | Y | 10498611 | CISPLATIN + RT |
| 10003919 | 10002470 | 1.67 | 59.8 | Curative (C) | 2018-07-13 | 2018-08-11 | CAPECITABINE + RT | 02 | N | 10499241 | CAPECITABINE + RT |
| 10003920 | 10002471 | 1.7 | 100.4 | Adjuvant (A) | null | 2017-08-01 | BCG Intravesical | N | Y | 10499282 | CAPECITABINE + CISPLATIN |
| 10003921 | 10002472 | 0 | 48.8 | null | 2018-08-23 | 2018-09-12 | Capecitabine 35days + RT | 02 | Y | 10499952 | CAPECITABINE + RT |
| 10003922 | 10002473 | 1.69 | 82 | null | 2015-02-03 | 2015-02-07 | CTD | 2 | N | 10500226 | CHLORAMBUCIL |
| 10003923 | 10002474 | 1.7 | 71.1 | Palliative (P) | null | 2014-07-18 | Cisplatin | N | Y | 10500362 | TEMOZOLOMIDE + RT |
| 10003924 | 10002475 | 1.72 | null | Neo-adjuvant (N) | 2015-11-09 | 2015-11-14 | CHOP - 21 days | 2 | N | 10500824 | CVD |
| 10003925 | 10002476 | 1.52 | 55.6 | null | 2016-12-20 | 2016-12-20 | Bortezomib + CYCLOPHOSPHAMIDE | N | N | 10501267 | FLUOROURACIL + MITOMYCIN + RT |
| 10003926 | 10002477 | null | 56.4 | Curative (C) | 2018-07-25 | 2018-07-26 | Cisplatin + Radiotherapy | 2 | null | 10501326 | CISPLATIN + RT |
| 10003927 | 10002478 | 1.77 | null | Curative (C) | 2019-01-04 | 2019-01-04 | Paclitaxel 7 day | 02 | N | 10501366 | CTD |
| 10003928 | 10002478 | 1.81 | 80.9 | Neo-adjuvant (N) | 2018-01-14 | 2018-01-16 | Fluorouricil + Folonic Acid (MdG) | N | N | 10501366 | FLUOROURACIL |
| 10003929 | 10002479 | 1.73 | 88 | null | 2017-06-20 | 2017-06-23 | ABVD | N | N | 10501566 | CVD |
| 10003930 | 10002480 | 1.61 | 60 | Adjuvant (A) | 2016-12-16 | 2017-01-15 | Fluorouricil + Folonic Acid (MdG) | 2 | N | 10501629 | FLUOROURACIL |
| 10003931 | 10002481 | 1.67 | 78.9 | Curative (C) | 2016-07-21 | 2016-08-05 | Cisplatin + Radiotherapy | N | Y | 10501698 | CISPLATIN + RT |
| 10003932 | 10002482 | 1.78 | 54 | Disease modification (D) | 2019-01-17 | 2019-01-21 | BCG Intravesical | 2 | N | 10501744 | CAPECITABINE + CISPLATIN |
| 10003933 | 10002483 | 1.75 | null | Disease modification (D) | 2015-12-15 | 2015-12-23 | IMATINIB | 2 | N | 10501772 | CVD |
| 10003934 | 10002483 | 1.76 | 82.8 | Adjuvant (A) | 2017-12-31 | 2018-01-15 | Fluorouricil + Folonic Acid (MdG) | 2 | N | 10501772 | FLUOROURACIL |
| 10003935 | 10002484 | 1.77 | 0 | Palliative (P) | null | 2014-03-21 | Bortezomib + CYCLOPHOSPHAMIDE | N | N | 10501802 | CHLORAMBUCIL |
| 10003936 | 10002485 | 1.74 | null | Palliative (P) | 2015-07-05 | 2015-07-11 | Fluorouracil+Mitomycin+RT (Anal Ca) | null | N | 10501876 | PACLITAXEL |
| 10003937 | 10002486 | 1.77 | 107 | Curative (C) | null | 2017-11-24 | Fluorouracil+Mitomycin+RT (Anal Ca) | Y | Y | 10501879 | CISPLATIN |
| 10003938 | 10002487 | 1.66 | 50 | Curative (C) | 2019-01-05 | 2019-01-26 | Bortezomib + CYCLOPHOSPHAMIDE | N | N | 10501975 | FLUOROURACIL + MITOMYCIN + RT |
| 10003939 | 10002487 | 150 | 68.6 | Curative (C) | 2017-12-29 | 2018-01-02 | CISPLATIN + RT | N | N | 10501975 | CISPLATIN + RT |
| 10003940 | 10002487 | 1.61 | null | Disease modification (D) | null | 2015-11-11 | Imatinib 400mg | N | null | 10501975 | AZACITIDINE |
| 10003941 | 10002488 | 1.59 | 86.8 | Palliative (P) | 2015-05-13 | 2015-06-07 | Temozolomide + RT | N | Y | 10502096 | BORTEZOMIB |
| 10003942 | 10006541 | 1.66 | 84 | Curative (C) | 2017-09-14 | 2017-10-25 | Paclitaxel 7 day | 02 | N | 10502113 | BCG |
| 10003943 | 10006541 | 1.64 | 90 | Palliative (P) | 2018-04-30 | 2018-05-12 | Irinotecan + Modified De Gramont | N | N | 10502113 | IRINOTECAN + MDG |
| 10003944 | 10002489 | 1.8 | 96.2 | Curative (C) | 2018-04-04 | 2018-04-04 | Chlorambucil | 02 | N | 10502161 | EC |
| 10003945 | 10002490 | 1.61 | 77.9 | Disease modification (D) | 2017-12-12 | 2017-12-15 | Cisplatin | N | N | 10502197 | CISPLATIN |
| 10003946 | 10002491 | 1.62 | 108 | Palliative (P) | 2015-01-06 | 2015-01-06 | CYCLOPHOSPHAMIDE + THALIDOMIDE | N | N | 10502211 | CISPLATIN + ETOPOSIDE |
| 10003947 | 10002491 | 0 | 77.4 | Disease modification (D) | 2015-02-26 | 2015-02-28 | CAPECITABINE + GEMCITABINE | 2 | N | 10502211 | TEMOZOLOMIDE + RT |
| 10003948 | 10002492 | 1.73 | null | Palliative (P) | 2017-11-16 | 2017-11-16 | CTD Attenuated (Thalidomide 50mg) | N | N | 10502231 | CTD |
| 10003949 | 10002492 | 0 | 58.1 | Adjuvant (A) | 2014-09-19 | 2014-09-21 | Bortezomib (weekly) | N | N | 10502231 | PACLITAXEL |
| 10003950 | 10002492 | 1.8 | 77.3 | Adjuvant (A) | 2014-04-02 | 2014-04-08 | Cisplatin 7 day | Y | N | 10502231 | CAPECITABINE + CISPLATIN |
| 10003951 | 10002493 | 1.65 | 82.75 | Palliative (P) | 2017-02-27 | 2017-03-21 | FLUOROURACIL | N | N | 10502299 | FLUOROURACIL |
| 10003952 | 10002493 | 1.62 | 120 | Curative (C) | 2017-12-03 | 2017-12-04 | Cisplatin + Radiotherapy | 2 | Y | 10502299 | CISPLATIN + RT |
| 10003953 | 10002494 | 1.81 | 76.2 | Palliative (P) | 2015-12-14 | 2015-12-25 | CHOP - 21 days | N | N | 10502333 | FLUOROURACIL + MITOMYCIN + RT |
| 10003954 | 10002495 | 1.62 | 111 | Palliative (P) | 2016-07-14 | 2016-07-24 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 10502374 | PACLITAXEL |